Sunitinib

Sunitinib is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST).

Sunitinib
 

Impurities available for : Sunitinib

Sunitinib N-Oxide
Sunitinib N-Oxide
CAS Number : 356068-99-0
CAT Number : ANT-SNB-03
Molecular Weight : 414.47
Molecular Formula : C22H27FN4O3
Stock Status : In Stock